World

US VP Vance discusses thorny issue of migration with Vatican

Apr 21, 2025

Vatican, April 21: US Vice President JD Vance has met with the Vatican's top diplomats, discussing the politically fraught issue of migration months after Pope Francis rebuked the new US administration's hardline immigration stance.
Vance, a Catholic convert, held what the Vatican described as "cordial talks" with Secretary of State Cardinal Pietro Parolin - the Holy See's second highest official after the pope - and Paul Richard Gallagher, the secretary for relations with states.
"There was an exchange of opinions on the international situation, especially regarding countries affected by war, political tensions and difficult humanitarian situations, with particular attention to migrants, refugees, and prisoners," the Vatican said in a statement.
The two sides also stressed "the common commitment to protect the right to freedom of religion and conscience", the Vatican said.
In February, Pope Francis angered the White House after writing a letter to US bishops in which he condemned Trump's plan to deport migrants en masse, describing it as a "major crisis".
Trump's border tsar told Francis to "stick to" religion.
Vance had been hoping to meet with the 88-year-old Francis, who is recuperating after battling life-threatening pneumonia and spending nearly 40 days in hospital.
The Vatican made no mention of any such meeting with the pontiff, who has resumed some official duties, and Vance's entourage has not commented on the remainder of his programme in Rome.
Source: Qatar Tribune

More news

Kapiva Partners with Central Council for Research in Ayurvedic Sciences (CCRAS) to Commercialise Clinically Evaluated Ayurvedic Formulations

New Delhi [India], September 17: Kapiva, one of India’s most trusted science-backed Ayurvedic brands, has entered into a strategic technology transfer and commercialisation alliance with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, to bring clinically evaluated Ayurvedic technologies and formulations to a wider consumer base.

Sep 17, 2026